FY2025 EPS Estimate for Trulieve Cannabis Cut by Analyst

Trulieve Cannabis Corp. (TSE:TRU) – Research analysts at Alliance Global Partners cut their FY2025 earnings per share estimates for Trulieve Cannabis in a research report issued to clients and investors on Wednesday, May 7th. Alliance Global Partners analyst A. Grey now expects that the company will earn ($0.28) per share for the year, down from their prior forecast of ($0.06). Alliance Global Partners also issued estimates for Trulieve Cannabis’ Q4 2025 earnings at ($0.01) EPS and FY2026 earnings at ($0.06) EPS.

TRU has been the subject of several other reports. Roth Capital raised Trulieve Cannabis to a “strong-buy” rating in a research report on Monday, March 3rd. Cormark upgraded Trulieve Cannabis from a “hold” rating to a “moderate buy” rating in a research note on Monday, March 3rd. Finally, Craig Hallum raised Trulieve Cannabis to a “strong-buy” rating in a report on Wednesday, February 26th.

Trulieve Cannabis Price Performance

Trulieve Cannabis Company Profile

TransUnion provides risk and information solutions. The company operates in three segments: U.S. Markets, International, and Consumer Interactive. The U.S. Markets segment provides consumer reports, actionable insights, and analytics to businesses. These businesses use its services to acquire new customers; assess consumer ability to pay for services; identify cross-selling opportunities; measure and manage debt portfolio risk; collect debt; verify consumer identities; and mitigate fraud risk.